Azeclear

Quick links to important sections

Azeclear

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Azeclear

Quick Facts

Property Description
Active ingredient Azelaic Acid (Nonanedioic Acid)
Form Topical Cream or Gel
Pharmacological class Topical Antiacne and Dermatological Agent
Route of administration Cutaneous (Topical)
Origin Synthetic (derived from natural sources)

Azeclear: Identity and Pharmacological Classification

Azeclear is a specialized topical medication defined by its active ingredient, Azelaic Acid (INN), which is chemically classified as a saturated dicarboxylic acid. The drug entity is categorized as a Topical Antiacne Agent and a Topical Anti-Rosacea Agent within pharmacological classifications. This agent is designed strictly for localized application onto the skin. Azelaic Acid is an active compound for treating inflammatory skin issues, characterized by its ability to reduce inflammation and normalize cell turnover processes.

Composition, Form, and Origin of Azelaic Acid

This preparation is intended for cutaneous administration, typically supplied in pharmaceutical dosage forms such as a topical cream (hydrophilic emulsion base) or an aqueous gel. The choice between these bases allows for optimized formulation based on the patient's skin type. Azelaic Acid is a single-active-ingredient formulation, chemically synthesized for pharmaceutical use, but is structurally based on a compound naturally found in certain cereal grains, including barley and rye.

General Purpose and Mechanism of the Preparation

The overall purpose of using preparations containing Azelaic Acid is to promote normalized skin appearance by addressing the multifaceted nature of inflammatory dermatological conditions, a benefit recognized for its efficacy. Azelaic Acid is used to stabilize the skin's surface environment. This comprehensive action allows the preparation to function as a comedolytic and antikeratinizing agent, which means it regulates skin cell growth within the hair follicles, and also reduces the microbial population and local inflammatory responses. This regulation helps to alleviate visible redness and inflammatory lesions.

Regulatory References

  1. NIH Drugs and Lactation Database - Azelaic Acid
  2. Drugs and Lactation Database (LactMed)

What side effects are possible with Azeclear?

Possible Side Effects and Safety Information

Azeclear (Azelaic Acid) is associated with adverse reactions that are primarily localized to the application site, reflecting its topical administration. The frequency of these effects is classified based on clinical trial and post-marketing surveillance data documented in regulatory reports.

Frequency-Classified Adverse Reactions

Classification Representative Adverse Reactions
Very Common (ge 10%) Application site burning, stinging, pruritus (itching), and tingling (paresthesia).
Common (1% to <10%) Application site erythema (redness), dryness, scaling, pain, and irritation.

These common effects are often related to the first few weeks of treatment and are noted in official labeling as potentially decreasing with continued use. The majority of reported effects are confined to the Skin and Subcutaneous Tissue Disorders system-organ class.

Serious Adverse Reactions and Safety Constraints

While systemic effects are rare due to minimal absorption, serious adverse reactions documented in regulatory sources include severe hypersensitivity reactions, such as angioedema (swelling of the face or throat) and, rarely, worsening of asthma symptoms. The medication is restricted for use in patients with a known history of hypersensitivity to Azelaic Acid or formulation components.

Population-Specific Notes

The medicine is for dermatologic use only; contact with the eyes and mucous membranes must be strictly avoided as this can cause severe irritation. For individuals with dark complexions, regulatory safety notes recommend monitoring for signs of hypopigmentation (skin color lightening).

Overdose and Emergency Response

Overdose and when to seek help

The regulatory profile for Azeclear (Azelaic Acid topical) indicates that acute systemic overdose from cutaneous application is not expected due to the negligible systemic absorption rate of the active substance. The official focus is directed toward severe local reactions and required emergency protocols.


Overdose Scope

Domain Official Regulatory Statements
Documented overdose presentations Excessive local skin irritation, potentially manifesting as severe burning, stinging, redness, dryness, or peeling.
Physiological systems affected Cutaneous system (local irritation). Ocular system (injury/inflammation from accidental contact, e.g., iridocyclitis). Systemic effects are limited to severe hypersensitivity reactions.
Emergency-response statements Contact a Poison Control Center immediately following accidental oral ingestion. Affected eyes or mucous membranes must be washed immediately and thoroughly with large amounts of water.

When to Seek Urgent Help

Classification Official Regulatory Statement
Immediate medical help required Immediate medical attention must be sought for any symptoms of a severe systemic hypersensitivity reaction, such as swelling of the face or throat, or trouble breathing (dyspnea).
Supportive management Management consists of symptomatic and supportive treatment. No specific antidote is documented.

Connection to the overall overdose profile

Regulatory documents define the overdose profile primarily around acute, non-systemic emergencies, necessitating immediate action for accidental ingestion and the emergence of severe, potentially life-threatening hypersensitivity reactions. This framing is a consequence of the low risk of systemic toxicity from typical topical use, guiding management toward specific supportive measures and physician consultation if irritation persists.

Therapeutic Uses of Azeclear

What Azeclear Treats: Main Uses and Benefits

Azeclear (Azelaic Acid) is commonly used to help manage several common dermatological conditions by addressing key symptomatic clusters, which contributes to improved comfort during periods of heightened symptoms. The primary focus of its use is on managing inflammatory lesions, clearing follicular blockages, and resolving post-inflammatory discoloration.

This medication is generally used to help manage the symptoms of Acne Vulgaris and papulopustular Rosacea, and is relevant for addressing Post-Inflammatory Hyperpigmentation (PIH) and Melasma. It is relevant in contexts where additional management of discomfort may be appropriate.

In these contexts, the medication assists in addressing symptom clusters that involve congested pores, heightened redness, and the formation of lesions (papules and pustules). It is considered relevant in conditions where symptoms may intensify temporarily. Azeclear generally provides support that helps ease the overall symptom load during periods when symptoms are more noticeable.


Quick Fact: Managing Inflammatory Symptoms

Domain Conditions Relevant Benefit Focus
Inflammatory Relief Acne Vulgaris, Rosacea Easing visible redness and swelling (papules, pustules)
Follicular Support Comedones (Blackheads/Whiteheads) Assisting with functional stability and comfort
Pigmentation Support PIH, Melasma Applied in addressing dark spots and discoloration

Regulatory References

  1. NIH MedlinePlus overview of Azelaic Acid

Eligibility and Restrictions for Use

Who Can and Cannot Use Azeclear?

Regulatory agencies define specific population eligibility for Azeclear (Azelaic Acid) through official classifications and documented limitations.

Eligibility Scope

Category Official Regulatory Classification
Populations for whom use is allowed Adults (generally 18 years); children 12 years of age and older (for some acne cream formulations).
Populations for whom use is contraindicated Individuals with known hypersensitivity or allergy to Azelaic Acid or any component of the specific formulation.
Age-related eligibility rules Not established in children under 12 years of age. Clinical data is insufficient for subjects 65 years and over to determine differential response.
Pregnancy and lactation eligibility status Pregnancy Category B: Use only if clearly needed. Lactation: Considered low risk; use is cautioned to avoid application to the breast or nipple area.
Eligibility-related restrictions For topical dermatologic use only. Use is prohibited on the eyes, mouth, and other mucous membranes.
Condition-specific eligibility rules Use with caution in patients with asthma due to potential for exacerbation. Monitoring for hypopigmentation is required for patients with dark complexions.

Connection to the Overall Eligibility Profile

Official regulatory documents strictly define eligibility by listing absolute prohibitions based on hypersensitivity and setting minimum age thresholds. The label also dictates conditional use during pregnancy and breastfeeding, while formally restricting application to non-mucosal, topical sites only.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official Interaction Profile Structure

The interaction profile of Azeclear (Azelaic Acid topical) is primarily characterized by the absence of documented systemic drug interactions. This is due to the minimal systemic absorption of the active ingredient, which results in circulating plasma levels comparable to those found in untreated individuals. Consequently, regulatory prescribing information confirms that no formal drug-drug interaction studies have been conducted for systemic medications.

Interaction-Related Restrictions and Constraints

While systemic interactions are not documented, restrictions apply to local products and certain substances to prevent irritation or symptom exacerbation:

  • Topical Co-Product Restriction: The co-administration of Azeclear with other topical irritants, such as alcohol-containing cleansers, tinctures, astringents, abrasives, or peeling agents, is restricted. This restriction prevents excessive local irritation or sensitization at the application site, as noted in the Warnings section of official labeling.
  • Disease-Trigger Restriction: For individuals using Azeclear to manage Rosacea, patient instructions advise the avoidance of consumption of alcoholic beverages, spicy foods, and thermally hot foods and drinks. These items are recognized as independent triggers that may provoke the condition's symptoms (erythema and flushing) during treatment, but this is a lifestyle constraint, not a pharmacological drug interaction.

Pharmacokinetic and Metabolic Summary

Due to minimal absorption, Azeclear is not expected to cause clinically significant alterations to the exposure (AUC/Cmax) of co-administered systemic drugs, and there are no known documented interactions involving major metabolic pathways like the CYP450 enzyme system.

Mechanism of Action

The mechanism of Azelaic Acid, the active component of Azeclear, is multifactorial, targeting three distinct biological domains simultaneously to influence multiple distinct biological pathways.

Normalization of Keratinocyte Differentiation

This domain involves the drug's role as a modulator of epithelial cell function within the hair follicle. Azelaic Acid normalizes the disordered proliferation and adhesion of keratinocytes, which structurally prevents excessive cellular accumulation and contributes to the maintenance of an unblocked follicular pore structure.

Modulation of Key Inflammatory Mediators

The molecule modulates multiple factors within the local inflammatory cascade by inhibiting the enzyme Kallikrein 5 (KLK5), which leads to the subsequent downregulation of the pro-inflammatory peptide Cathelicidin (LL-37). This mechanism, combined with scavenging Reactive Oxygen Species (ROS), results in the modulation of local tissue reactivity and decreased vascular signaling.

Bacteriostatic Effect on Skin Flora

Azelaic Acid targets the essential metabolic systems of Cutibacterium acnes, acting as an inhibitor of bacterial ribosomal protein synthesis and disrupting mitochondrial oxidoreductases. This bacteriostatic action limits the rapid multiplication of the microbe, effectively reducing the overall microbial concentration and subsequent generation of pro-inflammatory bacterial metabolites.

Dosage and Administration Information

How to Use Azeclear

Azeclear, a preparation containing Azelaic Acid, is designated strictly for topical use (cutaneous application) onto the affected skin areas. It is not approved for use in the eyes (ophthalmic), mouth (oral), or for internal application.


Standard Application Protocol

The standard frequency for administering Azeclear is twice daily, typically applied once in the morning and once in the evening. The preparation must be applied as a thin layer and gently massaged into the designated skin areas. The 15% gel formulation often requires a quantity of approximately 2.5 cm (one inch) of gel to cover the entire facial area.

For proper use, the skin must be thoroughly washed using a mild, soapless cleansing lotion and patted dry before application. Hands must be washed immediately after the medication has been applied.


Dosing and Duration

Indication-Based Form Standard Dosage (Adults/Adolescents) Duration Principle
Acne Vulgaris (20% Cream) Twice daily application. Generally used over several months for optimal results.
Papulopustular Rosacea (15% Gel/Foam) Twice daily application. Treatment should be reassessed if no improvement is seen after 12 weeks of therapy.

Azeclear is approved for use in adolescents 12 years of age and older, with no specific dose adjustment required based on age within that range. A key procedural principle is that if excessive or persistent skin irritation occurs, the application frequency may be temporarily reduced to once daily or interrupted entirely until the irritation subsides.


Recent Clinical Evidence

Research Evidence / Overview of Studies for Azeclear

Evidence for Use in Acne Vulgaris

Research has primarily focused on Azeclear's use for treating acne that involves inflammatory or irritative states on the skin, typically in adolescent and adult populations. The main types of research conducted are short-term to mid-term Randomized Controlled Trials (RCTs) and comprehensive systematic reviews. These studies monitored changes measured during the study period, such as the count of both inflammatory lesions and non-inflammatory lesions.

The findings describe patterns observed in these studies where measurements of lesion counts and overall global skin assessments data show patterns related to changes over the observation periods. Some trials reported that the measured change in lesion and severity counts were within the range reported for certain other topical treatments. The evidence is limited in providing details on long-term outcomes beyond six months of continuous use. Research is lacking regarding the use of Azeclear in children younger than 12 years of age.

Evidence for Use in Papulopustular Rosacea

Azeclear was evaluated in numerous controlled clinical trials specifically for conditions characterized by fluctuating or episodic manifestations of rosacea, particularly the papulopustular subtype. The researchers examined outcomes linked to inflammatory or irritative states, such as the count of inflammatory lesions and the severity of persistent facial redness.

The evidence contributes to understanding symptom patterns by reporting measurements of lesion counts and redness severity that data show patterns related to short-term changes compared to the vehicle formulation. Some comparisons to topical metronidazole reported that the observed measurements in lesion and erythema severity endpoints were in a comparable range. What remains uncertain is the agent’s role in managing rosacea subtypes other than the papulopustular form, and evidence is limited on the degree to which persistent telangiectasia (visible blood vessels) changes in response to the application of this agent.

What is Still Uncertain About Azeclear Research

Research highlights what is known — and what is still uncertain — about the use of this agent. A key limitation is that many studies focus on short-term symptom changes, and the long-term effects are not fully established for all conditions. Additionally, comparative evidence is lacking for many new or combination therapies now available on the market. The results apply only to the populations studied, and findings describe group patterns, not personal outcomes.

Key Studies & References A Comprehensive Review of Azelaic Acid Pharmacological Properties, Clinical Applications, and Innovative Topical Formulations

Frequently Asked Questions (FAQ)

Common questions about Azeclear (FAQ)


Q: What happens if I stop taking Azeclear suddenly?

Official labeling recommends using the preparation for the full prescribed treatment period. Stopping Azeclear prematurely may affect the expected treatment outcome. The potential for the underlying condition to reappear should be discussed with a healthcare provider.


Q: What should I know about taking Azeclear with certain foods?

Official patient instructions advise individuals managing Rosacea to avoid consuming spicy foods, thermally hot foods and drinks, and alcoholic beverages. These items are recognized as factors that may provoke the condition’s symptoms, such as redness and flushing, independently of the medication.


Q: Is a metallic taste in the mouth listed as a possible side effect of Azeclear?

Regulatory sources note that changes in taste have been reported as a less common adverse reaction. This type of effect is not among the very common or common application site reactions. Any persistent or concerning changes should be reviewed as part of regular medical monitoring.


Q: Are the initial side effects of Azeclear temporary?

Initial reactions localized to the application site, such as burning, stinging, or itching, are described in official documents as being temporary. These effects often subside with continued use, typically diminishing within the first few weeks of treatment.


Q: Do I need regular blood tests while on Azeclear?

Official documentation notes that minimal systemic absorption occurs, meaning only a very small amount of the active ingredient enters the bloodstream. This results in circulating levels comparable to what is found naturally, and official information does not indicate that routine systemic monitoring or blood tests are required.


Q: Can I take Azeclear if I am pregnant or breastfeeding?

Official classification notes that use during pregnancy is conditional and should occur only if clearly needed. For lactation, Azeclear is considered low risk due to minimal absorption; however, a specific precaution advises against applying the preparation to the breast or nipple area.


Q: What should I do if I forget a dose of Azeclear?

Official patient instructions describe a procedure for missed applications, which involves applying the missed dose when remembered unless the next scheduled dose is nearly due. Double application to compensate for a forgotten dose is not advised.


Q: Do studies show that Azeclear is effective for long-term use?

Official research summaries note that clinical evidence is primarily focused on short-term to mid-term outcomes for the approved conditions. Evidence detailing long-term effects beyond six months of continuous use is limited, according to the available clinical data.


Q: Are there specific vitamins or supplements that should be avoided while on Azeclear?

The regulatory profile notes the absence of documented systemic drug interactions for most oral medications, due to the minimal absorption of the topical agent. Restrictions are primarily noted for avoiding local topical irritants, such as alcohol-containing cleansers or peeling agents.


Q: Can older adults use Azeclear safely?

Official documentation states that clinical studies for Azeclear did not include sufficient numbers of subjects aged 65 and over. Because of this limitation, it cannot be determined whether they respond differently from younger individuals, according to the available clinical data.


Q: Can Azeclear be taken with other medications for the same condition?

Regulatory documents note the absence of documented systemic drug interactions. However, official information restricts the co-administration of Azeclear with other topical irritants, such as alcohol-containing cleansers or abrasives, to prevent excessive local irritation.


Q: Why do some people say Azeclear made them feel tired?

Official regulatory side effect data for Azeclear does not list tiredness or fatigue as a common or very common adverse reaction. The reported adverse reactions are primarily localized to the application site.


Q: How long does Azeclear stay in your system?

Pharmacokinetic data indicates that Azeclear is rapidly absorbed into the systemic circulation after topical application. The observed half-life, which represents the time it takes for half of the substance to be eliminated, is approximately 12 hours.


Q: Is Azeclear a prescription-only medicine?

Yes, official government drug information consistently references Azeclear as a product that requires a valid prescription for use. Regulatory sources classify this medication as requiring a prescription for use.


Q: Can stress affect how Azeclear works?

Official patient instructions for Rosacea management advise avoiding stress. Stress is recognized as an independent factor that may provoke the condition’s symptoms, such as facial redness and flushing, regardless of the medication being used.


Q: What do official sources say about the safety profile of Azeclear?

The safety profile is primarily characterized by adverse reactions localized to the application site, with minimal systemic absorption. Serious, but rare, reactions documented in regulatory sources include severe hypersensitivity reactions and worsening of asthma symptoms.

How should Azeclear be stored and disposed of?

How to Store and Dispose of Azelaic Acid Preparations (Azeclear)

Storage and disposal requirements for Azelaic Acid are set by regulatory agencies to ensure product integrity and safety.


Official Storage Conditions

Temperature and Protection: The preparation must be stored at controlled room temperature, typically between 15 C and 30 C (59 F and 86 F). It is mandatory to protect the product from freezing and excessive heat, moisture, or light.

Handling and Stability: The medicine should be kept in its original container and the cap must remain tightly closed. After the container is first opened, the product has a specific in-use shelf-life (e.g., 8 weeks or 6 months), after which any remaining product must be discarded.


Disposal and Child Safety

All Azelaic Acid preparations must be kept out of the sight and reach of children. Unused or expired medication should not be disposed of in wastewater or household trash. Consult a healthcare professional or local authority for instructions on proper pharmaceutical waste disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Azeclear found in:

A-Z Index: